From Dermatological Examination to Systemic Diagnosis: Sézary Syndrome

Authors

DOI:

https://doi.org/10.24950/rspmi.2730

Keywords:

Dermatitis, Exfoliative, Lymphoma, T-Cell, Cutaneous/ diagnosis, Sezary Syndrome/diagnosis

Downloads

Download data is not yet available.

References

1. Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol. 2019;94:1027-41. doi: 10.1002/ajh.25577.

2. Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113:5064-73. doi: 10.1182/blood-2008-10-184168.

3. Thompson AK, Killian JM, Weaver AL, Pittelkow MR, Davis MD. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic. J Am Acad Dermatol. 2017;76:683-8. doi: 10.1016/j.jaad.2016.10.029.

4. Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, et al. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. Br J Dermatol. 2015;173:93-105. doi: 10.1111/bjd.13832.

Published

2026-08-26

How to Cite

1.
Lança Pereira J, Veigas E, Rodrigues dos Reis F, Oliveira E. From Dermatological Examination to Systemic Diagnosis: Sézary Syndrome. RPMI [Internet]. 2026 Aug. 26 [cited 2026 Sep. 17];(XX). Available from: https://revista.spmi.pt/index.php/rpmi/article/view/2730

Issue

Section

Images in Medicine

Categories